Oncolix, Inc., Corporation just released form D about $200,000 debt financing. This is a new filing. Oncolix was able to finance itself with $150,000 so far. That is 75.00% of the financing offer. The total private offering amount was $200,000. The fundraising form was filed on 2016-10-03. The reason for the financing was: unspecified. The fundraising still has about $50,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Oncolix is based in Texas. The company’s business is Biotechnology. The form D was submitted by JD Payne Senior VIce President. The company was incorporated more than five years ago. The filler’s address is: 14405 Walters Road, Suite 780, Houston, Tx, Texas, 77014. Michael T Redman is the related person in the form and it has address: 14405 Walters Rd Ste 780, Houston, Tx, Texas, 77014. Link to Oncolix Filing: 000157406116000004.
Analysis of Oncolix Offering
On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Oncolix sold 75.00% of the offering. The financing is still open. Could this mean that the trust in Oncolix is high? The average fundraising size for companies in the Biotechnology industry is $3.08 million. The offering was 95.13% smaller than the average of $3.08 million. Of course this should not be interpreted as negative. Firms get financed for different needs and reasons. The minimum investment for this fundraising is set at $50000. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Oncolix Also
The Form D signed by JD Payne might help Oncolix, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.